Nephros INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NASDAQ
Nephros, Inc. announced record second-quarter net revenue of $6 million, a 36% increase year-over-year, alongside a significant jump in net income to $1.2 million.
NASDAQ
Nephros Inc. announced first-quarter 2026 financial results, showing a 7% increase in net revenue to $5.2 million, driven by core programmatic business growth, but facing margin pressure from tariffs and currency fluctuations.
NASDAQ
Nephros, Inc. announced the posting of its updated 2026 Corporate Presentation on its corporate website via an 8-K filing.
NASDAQ
Nephros, Inc. has entered into a new exclusive license and supply agreement with Medica S.p.A. for filtration products, replacing a prior agreement and outlining significant purchase commitments through 2030.
NASDAQ
Nephros, Inc. announced robust second-quarter 2025 financial results, achieving $4.4 million in net revenue and its third consecutive quarter of profitability.
NASDAQ
Nephros, Inc. announced the successful election of a director, ratification of its independent accounting firm, and advisory approval of executive compensation at its 2025 Annual Meeting of Stockholders.
NASDAQ
Nephros reports a significant increase in first-quarter revenue, driven by growth in both its core programmatic and emergency response businesses, leading to profitability.
NASDAQ
Alisa Lask will not seek re-election to Nephros, Inc.'s Board of Directors at the upcoming annual meeting on June 16, 2025.
NASDAQ
Nephros Inc. released an updated corporate presentation for 2024 on March 31, 2025.
NASDAQ
Nephros reports its first profitable quarter and fiscal year, driven by a 19% increase in fourth-quarter revenue and effective cost management.
NASDAQ
Nephros Inc. has amended its agreement with CFO Judith Krandel, granting her stock options and increasing her annual performance bonus target.
NASDAQ
Nephros, Inc. reports its first profitable quarter with a net income of $0.2 million, despite a slight year-over-year revenue decrease.
NASDAQ
Nephros, Inc. has released an updated corporate presentation on its website on August 26, 2024.
NASDAQ
Nephros Inc. held its 2024 Annual Meeting where stockholders approved a new equity incentive plan, elected two directors, and ratified the appointment of their accounting firm.
NASDAQ
Nephros announced its first quarter 2024 financial results, highlighting a 12% year-over-year growth in its programmatic business despite a slight overall revenue decrease.
NASDAQ
Nephros, Inc. presented its 2024 corporate strategy at the Planet MicroCap Showcase: VEGAS 2024 on May 1, 2024.
NASDAQ
Nephros Inc. announced a 43% increase in full-year revenue and a significant reduction in net loss for 2023, driven by streamlined operations and increased demand for their filtration solutions.